135 related articles for article (PubMed ID: 34955382)
21. Dental age in patients with neurofibromatosis 1.
Jääsaari P; Visnapuu V; Nyström M; Peltonen S; Peltonen J; Happonen RP
Eur J Oral Sci; 2012 Dec; 120(6):549-52. PubMed ID: 23167472
[TBL] [Abstract][Full Text] [Related]
22. Periapical Cemento-osseous Dysplasia Is Rarely Diagnosed on Orthopantomograms of Patients with Neurofibromatosis Type 1 and Is Not a Gender-specific Feature of the Disease.
Friedrich RE; Reul A
Anticancer Res; 2018 Apr; 38(4):2277-2284. PubMed ID: 29599350
[TBL] [Abstract][Full Text] [Related]
23. [Developmental manifestation in children with neurofibromatosis type 1].
Cohen R; Shuper A
Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
[TBL] [Abstract][Full Text] [Related]
24. Neurofibromatosis type 1 of the child increases birth weight.
Leppävirta J; Kallionpää RA; Uusitalo E; Vahlberg T; Pöyhönen M; Peltonen J; Peltonen S
Am J Med Genet A; 2019 Jul; 179(7):1173-1183. PubMed ID: 31016862
[TBL] [Abstract][Full Text] [Related]
25. NF1 gene and neurofibromatosis 1.
Rasmussen SA; Friedman JM
Am J Epidemiol; 2000 Jan; 151(1):33-40. PubMed ID: 10625171
[TBL] [Abstract][Full Text] [Related]
26. Social functioning in adults with neurofibromatosis type 1.
Pride NA; Crawford H; Payne JM; North KN
Res Dev Disabil; 2013 Oct; 34(10):3393-9. PubMed ID: 23911645
[TBL] [Abstract][Full Text] [Related]
27. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
[TBL] [Abstract][Full Text] [Related]
28. NF1 Somatic Mutation in Dystrophic Scoliosis.
Margraf RL; VanSant-Webb C; Mao R; Viskochil DH; Carey J; Hanson H; D'Astous J; Grossmann A; Stevenson DA
J Mol Neurosci; 2019 May; 68(1):11-18. PubMed ID: 30778836
[TBL] [Abstract][Full Text] [Related]
29. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.
De Luca A; Bottillo I; Sarkozy A; Carta C; Neri C; Bellacchio E; Schirinzi A; Conti E; Zampino G; Battaglia A; Majore S; Rinaldi MM; Carella M; Marino B; Pizzuti A; Digilio MC; Tartaglia M; Dallapiccola B
Am J Hum Genet; 2005 Dec; 77(6):1092-101. PubMed ID: 16380919
[TBL] [Abstract][Full Text] [Related]
30. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
31. Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1.
McCaughan JA; Holloway SM; Davidson R; Lam WW
J Med Genet; 2007 Jul; 44(7):463-6. PubMed ID: 17327286
[TBL] [Abstract][Full Text] [Related]
32. Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1.
Rance G; Zanin J; Maier A; Chisari D; Haebich KM; North KN; Dabscheck G; Seal ML; Delatycki MB; Payne JM
JAMA Netw Open; 2021 Dec; 4(12):e2136842. PubMed ID: 34870681
[TBL] [Abstract][Full Text] [Related]
33. Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules.
Ben-Shachar S; Dubov T; Toledano-Alhadef H; Mashiah J; Sprecher E; Constantini S; Leshno M; Messiaen LM
J Am Acad Dermatol; 2017 Jun; 76(6):1077-1083.e3. PubMed ID: 28318682
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.
Evans DGR; Kallionpää RA; Clementi M; Trevisson E; Mautner VF; Howell SJ; Lewis L; Zehou O; Peltonen S; Brunello A; Harkness EF; Wolkenstein P; Peltonen J
Genet Med; 2020 Feb; 22(2):398-406. PubMed ID: 31495828
[TBL] [Abstract][Full Text] [Related]
35. Lifetime distributional effects of Social Security retirement benefits.
Smith K; Toder E; Iams H
Soc Secur Bull; 2003-2004; 65(1):33-61. PubMed ID: 15218634
[TBL] [Abstract][Full Text] [Related]
36. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
37. Congenital Retroperitoneal Teratoma in Neurofibromatosis Type 1.
Yap P; Super L; Qin J; Burgess T; Prodanovic Z; Edwards C; Thomas R; Carpenter K; Tan TY
Pediatr Blood Cancer; 2016 Apr; 63(4):706-8. PubMed ID: 26514327
[TBL] [Abstract][Full Text] [Related]
38. Predictors of cognitive, behavioural and academic difficulties in NF1.
Geoffray MM; Robinson L; Ramamurthy K; Manderson L; O'Flaherty J; Lehtonen A; Tordjman S; Green J; Vassallo G; Garg S
J Psychiatr Res; 2021 Aug; 140():545-550. PubMed ID: 34182240
[TBL] [Abstract][Full Text] [Related]
39. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France.
Duong TA; Sbidian E; Valeyrie-Allanore L; Vialette C; Ferkal S; Hadj-Rabia S; Glorion C; Lyonnet S; Zerah M; Kemlin I; Rodriguez D; Bastuji-Garin S; Wolkenstein P
Orphanet J Rare Dis; 2011 May; 6():18. PubMed ID: 21542925
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of neurofibromatosis type 1.
Friedman JM
Am J Med Genet; 1999 Mar; 89(1):1-6. PubMed ID: 10469430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
